These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27316562)

  • 1. Production of citramalate by metabolically engineered Escherichia coli.
    Wu X; Eiteman MA
    Biotechnol Bioeng; 2016 Dec; 113(12):2670-2675. PubMed ID: 27316562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eliminating acetate formation improves citramalate production by metabolically engineered Escherichia coli.
    Parimi NS; Durie IA; Wu X; Niyas AMM; Eiteman MA
    Microb Cell Fact; 2017 Jun; 16(1):114. PubMed ID: 28637476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of citramalic acid from glycerol by metabolically engineered Escherichia coli.
    Wu X; Eiteman MA
    J Ind Microbiol Biotechnol; 2017 Oct; 44(10):1483-1490. PubMed ID: 28744578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered citrate synthase improves citramalic acid generation in Escherichia coli.
    Wu X; Tovilla-Coutiño DB; Eiteman MA
    Biotechnol Bioeng; 2020 Sep; 117(9):2781-2790. PubMed ID: 32497258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient bio-production of citramalate using an engineered Escherichia coli strain.
    Webb JP; Arnold SA; Baxter S; Hall SJ; Eastham G; Stephens G
    Microbiology (Reading); 2018 Feb; 164(2):133-141. PubMed ID: 29231156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic engineering of Escherichia coli W3110 to produce L-malate.
    Dong X; Chen X; Qian Y; Wang Y; Wang L; Qiao W; Liu L
    Biotechnol Bioeng; 2017 Mar; 114(3):656-664. PubMed ID: 27668703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate synthase variants improve yield of acetyl-CoA derived 3-hydroxybutyrate in Escherichia coli.
    Rajpurohit H; Eiteman MA
    Microb Cell Fact; 2024 Jun; 23(1):173. PubMed ID: 38867236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-encoded biosynthetic genes alleviate metabolic disadvantages while increasing glucose conversion to shikimate in an engineered Escherichia coli strain.
    Rodriguez A; Martínez JA; Millard P; Gosset G; Portais JC; Létisse F; Bolivar F
    Biotechnol Bioeng; 2017 Jun; 114(6):1319-1330. PubMed ID: 28186321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy as design principle for metabolic engineering of 1-propanol production in Escherichia coli.
    Shen CR; Liao JC
    Metab Eng; 2013 May; 17():12-22. PubMed ID: 23376654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliminating side products and increasing succinate yields in engineered strains of Escherichia coli C.
    Jantama K; Zhang X; Moore JC; Shanmugam KT; Svoronos SA; Ingram LO
    Biotechnol Bioeng; 2008 Dec; 101(5):881-93. PubMed ID: 18781696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improving glycolic acid yield by metabolic engineering in Escherichia coli].
    Ma N; Zhu K; Mao Y; Deng Y
    Sheng Wu Gong Cheng Xue Bao; 2018 Feb; 34(2):224-234. PubMed ID: 29424136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted optimization of central carbon metabolism for engineering succinate production in Escherichia coli.
    Zhao Y; Wang CS; Li FF; Liu ZN; Zhao GR
    BMC Biotechnol; 2016 Jun; 16(1):52. PubMed ID: 27342774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoleucine biosynthesis in Leptospira interrogans serotype lai strain 56601 proceeds via a threonine-independent pathway.
    Xu H; Zhang Y; Guo X; Ren S; Staempfli AA; Chiao J; Jiang W; Zhao G
    J Bacteriol; 2004 Aug; 186(16):5400-9. PubMed ID: 15292141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based metabolic engineering enables high yield itaconic acid production by Escherichia coli.
    Harder BJ; Bettenbrock K; Klamt S
    Metab Eng; 2016 Nov; 38():29-37. PubMed ID: 27269589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic engineering of Escherichia coli for the production of 1-propanol.
    Choi YJ; Park JH; Kim TY; Lee SY
    Metab Eng; 2012 Sep; 14(5):477-86. PubMed ID: 22871504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of an Escherichia coli strain engineered in the substrate uptake system for improved culture performance at high glucose and cell concentrations: an alternative to fed-batch cultures.
    Lara AR; Caspeta L; Gosset G; Bolívar F; Ramírez OT
    Biotechnol Bioeng; 2008 Mar; 99(4):893-901. PubMed ID: 17929322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Succinate from Acetate by Metabolically Engineered Escherichia coli.
    Li Y; Huang B; Wu H; Li Z; Ye Q; Zhang YP
    ACS Synth Biol; 2016 Nov; 5(11):1299-1307. PubMed ID: 27088218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of malate production through engineering of the periplasmic rTCA pathway in Escherichia coli.
    Guo L; Zhang F; Zhang C; Hu G; Gao C; Chen X; Liu L
    Biotechnol Bioeng; 2018 Jun; 115(6):1571-1580. PubMed ID: 29476618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic engineering of isopropyl alcohol-producing Escherichia coli strains with
    Okahashi N; Matsuda F; Yoshikawa K; Shirai T; Matsumoto Y; Wada M; Shimizu H
    Biotechnol Bioeng; 2017 Dec; 114(12):2782-2793. PubMed ID: 28755490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent Synthesis of Two Heterogeneous Fluxes from Glucose and Acetate for High-Yield Citramalate Production.
    Nam SH; Ye DY; Hwang HG; Jung GY
    J Agric Food Chem; 2024 Mar; 72(11):5797-5804. PubMed ID: 38465388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.